ATE: Investor

Source the next wave of biotech breakthroughs

Join Europe's most senior CGT investment community for curated access to the startups, scaleups, and innovators shaping tomorrow's therapies.

As an investor, you get complimentary access to a pre-approved audience of biotech founders, academic pioneers, and industry leaders.

  • Take part in 1:1 partnering with early-stage and growth-stage biotech companies
  • Discover the most promising innovations through our live Innovation Exchange
  • Gain expert insight into investment trends, scalable technologies, and commercialisation timelines
  • Join the Investor Summit to connect with your peers, LPs, and fund managers
  • Participate as a judge, moderator, or roundtable leader

 

Discover Advanced Therapies Week as an investor

Explore how Advanced Therapies Week empowers biotechs to accelerate their commercialization journey. From engaging with investors at our exclusive Investor Pre-Day to building valuable partnerships with industry leaders, every moment is designed to drive your success. Dive into the agenda, connect with peers, and meet solution providers ready to support your growth.

Content Packed Agenda

Start with macro and micro trends shaping CGT investment — from capital flows to platform-based valuations.

Founders in Focus

Biotech CEOs share real-world experiences in securing funding, navigating milestones, and scaling in complex markets.

Investor Sessions

Get behind-the-scenes access to the thinking of investors from firms like BroadOak Capital Partners, 4BIO Capital, and Saisei Ventures.

Strategic Networking

1:1 meetings and informal conversations with decision-makers continue throughout ATE — the summit is your introduction.

Key themes to discover

  • Access curated discussions on market trends, valuation shifts, and risk frameworks and enable sharper decision-making and deal selection.

  • See pre-vetted companies present their value proposition in real-time and efficiently scan pipeline potential and find hidden gems.

  • Learn which CGT business models are surviving current market pressures to better identify who will deliver ROI.

  • Pre-schedule meetings with founders and fellow VCs to accelerate diligence and fosters co-investment opportunities.

Must attend sessions

  • Panel: Bridging the funding gap – How to get from pre-clinical to clinical without stalling out

  • Panel: The reality of raising funds for CGT startups

  • Innovation Exchange (startups pitch to investors)

  • Panel: The state of the CGT industry & turning the future into action

  • Roundtables: Investor expectations: what do you need for each funding stage?

View our agenda

Who Might You Find On the Show Floor?

Sample Attendee List Current Exhibitor List

500+
Attendees
40+
Countries
150+
Speakers
170+
Therapeutic Developers

 

  • “I get SO MUCH information at this show that sets me up for the year. It’s what I love about it. To me, ATW is the start of the year.”
    Principal, WMC
  • “The Super Bowl of Advanced Cell Therapy conferences.”
    Patient & Author, Killing Cancer with TILs
  • "Everyone that has a word to say, or a finger on the lifecycle of a cell therapy product should come here…”
    President & CEO, Co-founder, NKILT Therapeutics Inc.
  • “Advanced Therapies Week has been the epicenter of the cell & gene therapy revolution. This is a dynamic and must-attend forum where breakthrough technologies and impactful partnerships come to life to transform drug development.”
    Bullpen